Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.2K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.5K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.5K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.3K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

2.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretable modality-aware mapping of gene regulation in single-cell multiomics with scMAGCA.

Nature communications·2026
Same author

Bridging sequence-structure motifs and genetic variants for genome-wide dynamic RNA-protein interaction profiling.

Nature communications·2026
Same author

Pre-training genomic language model with variants for better modeling functional genomics.

NPJ artificial intelligence·2026
Same author

Gero-LLM: A Multimodal Large Language Model for Geroprotector Discovery via Cross-Modal Differentiated Mutual Learning.

IEEE journal of biomedical and health informatics·2026
Same author

Accurate and interpretable ADMET prediction: Integrating structural, geometric, and global molecular context representations.

European journal of medicinal chemistry·2026
Same author

Orthogonal disentanglement of single-cell multi-omics reveals private and shared drivers of tissue development and pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Aug 24, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation.

Lei Huang1, Jiecong Lin2,3, Rui Liu1

  • 1Department of Computer Science, City University of Hong Kong, Hong Kong SAR.

Briefings in Bioinformatics
|October 24, 2022
PubMed
Summary

We developed CoaDTI, a deep learning framework for efficient drug-target interaction prediction. Transfer learning enhances performance, enabling identification of novel drug-target interactions and providing mechanistic insights.

Keywords:
Drug–target interactionco-attentiondeep learningmulti-mode

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Aug 24, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Computational biology
  • Drug discovery
  • Bioinformatics

Background:

  • Accurate drug-target interaction (DTI) identification is crucial for in silico drug discovery.
  • Manual DTI annotation is laborious and time-consuming.
  • Existing high-throughput prediction methods often rely on error-prone manual features.

Purpose of the Study:

  • To develop an efficient and interpretable deep learning framework for drug-target annotation.
  • To improve the accuracy and reduce the reliance on manual features in DTI prediction.

Main Methods:

  • Developed CoaDTI, an end-to-end deep learning framework utilizing a co-attention mechanism.
  • Employed transformer for protein representation learning from amino acid sequences.
  • Utilized GraphSage for extracting molecule graph features from SMILES.
  • Implemented transfer learning with pre-trained transformers to address limited labeled data.

Main Results:

  • CoaDTI achieved competitive performance on three public datasets compared to state-of-the-art models.
  • Transfer learning significantly boosted prediction performance.
  • Identified novel DTIs, including potential interactions with SARS-CoV-2 associated proteins.
  • CoaDTI's co-attention mechanism provided interpretable insights into predicted interactions.

Conclusions:

  • CoaDTI offers an efficient and interpretable solution for drug-target annotation.
  • Transfer learning is a valuable strategy for enhancing DTI prediction with scarce data.
  • The framework has the potential to accelerate drug discovery by identifying novel DTIs.